Evaluating aspects of the SARS-CoV-2 whole genome sequencing process for implementation into COVID-19 genomic surveillance program for Canada
Raw reads of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from Canadian clinical samples and cultured isolates collected between 2020 to 2022 for implementation of whole genome sequencing into Canada's COVID-19 genomic surveillance program.